TE_10929
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | L1PBa1_5end |
|---|---|
| TE superfamily | L1 |
| TE class | LINE |
| Gene | - |
| Class | Intergenic |
| Coding | Non-coding |
| Tumor-specific score | 189.35 |
| Counts of samples | TCGA_tumor:167; TCGA_normal:0; GTEx:0 |
| TSS | chr4(+):121411774 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_10929.31 | - | Intergenic | Non-coding | Non-coding | chr4(+):121411775,121411885,121482784,121482864,121489991,121490045,121578785,121578844,121581672,121581692 |
| teRNA_10929.32 | - | Intergenic | Non-coding | Non-coding | chr4(+):121411775,121411885,121482784,121482864,121489991,121490045,121524673,121524773,121525173,121525284,121551529,121551588,121594414,121594612,121596760,121596780 |
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
